Back

Electronegative ApoCIII-Rich HDL promotes cellular damage and vascular aging

2 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Lipids: new pathophysiological and therapeutic insights Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Wen-Li Hsu

National Health Research Institute, Yunlin (Taiwan)

6 More presentations in this session

Presentation thumbnail
Rare genetic variants in LDLR, APOB, and PCSK9 are associated with aortic stenosis
Mr S. Jurgens (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Lipidomics-based deep learning algorithms can enhance prediction of obstructive coronary artery disease
Doctor E. Karagiannidis (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Peroxisome proliferator-activated receptor gamma regulates interleukin-6 induced lipoprotein(a) gene expression in human HepG2 cells
Doctor T. Harb (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associated steatohepatitis in mice
Doctor S. Pagano (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Beyond LDL-cholesterol: effects of alirocumab on the human apolipoproteome
Mr L. Schmidt (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids: new pathophysiological and therapeutic insights

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Electronegative H5 HDL: an apo(a)-containing HDL that damages neuronal DNA by potentially disrupting the BBB
29 August 2025
thumbnail
Congress Session
Traditional and emerging factors driving population outcomes
30 August 2025
thumbnail
Congress Presentation
Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL
30 August 2025
thumbnail
Congress Presentation
S1P content as a characteristic of the cardioprotective properties of HDL in coronary heart disease and diabetes mellitus
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources